Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients
Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients have?
Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients published?
Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients has 2020 year in the ScholarIQ index.
What is the open-access status of Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients?
Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients has closed oa status in the ScholarIQ index.
What is the DOI of Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients?
The DOI for Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients is on the source record.
What is the OpenAlex record for Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients?
The OpenAlex for Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients is on the source record.